OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 1.

Table. 1.

Patient and sample characteristics

Characteristic N (%)
Patients 54
Age, yr, median (range) 9 (1–18)
Sex, Male:Female 1:1.1
Genetic abnormalities
BCR::ABL1 8 (14.8)
TCF3::PBX1 7 (13.0)
ETV6::RUNX1 6 (11.1)
KMT2A rearrangement 1 (1.9)
Other karyotypic abnormalities 25 (46.3)
Normal karyotype 7 (13.0)
Samples 139
Post-induction 35 (25.2)
Post-consolidation 34 (24.5)
Post-maintenance 14 (10.1)
Post-chimeric antigen receptor T cell therapy 16 (11.6)
Post-immunotherapy (blinatumomab or inotuzumab) 6 (4.3)
Post-hematopoietic stem cell transplantation 34 (24.5)
Ann Lab Med 2024;44:354~358 https://doi.org/10.3343/alm.2023.0412

© Ann Lab Med